Breast Cancer
Conference Coverage
Study finds spironolactone doesn’t boost breast cancer recurrence
Little is known about its use in treating alopecia in breast cancer survivors on endocrine therapies.
News
CLL and breast cancer differ in the expression of regulatory microRNAs
A particular microRNA was found to be associated with prevascular invasion.
News
Cancer care and COVID-19 in Seattle, the first U.S. epicenter
Article
How is oncology adapting to COVID-19?
Opinion
Responsible use of breast cancer screening
Dr. Alan P. Lyss reviews a study suggesting that women aged 75 years and older do not benefit from annual mammography.
News
Disruptions in cancer care in the era of COVID-19
News
‘Like a coin flip’: Assay denies some cancer patients new drug
Investigators find fault with an assay used to determine which triple-negative breast cancer patients are eligible to receive atezolizumab.
News
Study supports genetic testing for all breast cancer patients age 65 and younger
Opinion
Real-world data are a wake-up call
Dr. Alan P. Lyss analyzes research showing treatment doesn’t correspond to guidelines in breast cancer patients with deleterious germline...
Conference Coverage
Largest meeting on cancer research canceled: AACR